Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Mark A, Dayton"'
Autor:
Sandra Milan, Jon P. Gockerman, Kimberly Denis-Mize, Maurice J. Wolin, Alan Yuen, Alexandra Levine, William Larry Gluck, Susan E. Wilson, Mark A. Dayton, Barbara Tong, Dawn Navis, Jennifer Lucas, Deborah Hurst, Anita Difrancesco
Publikováno v:
Clinical Cancer Research. 10:2253-2264
Purpose: Expansion and activation of natural killer (NK) cells with interleukin-2 (IL-2) may enhance antibody-dependent cellular cytotoxicity (ADCC), an important mechanism of rituximab activity. Two parallel Phase I studies evaluated combination the
Autor:
Mylinh Smith, M. Javad Khosravi, Herbert Yu, Anastasia Diamandi, Benjamin D.L. Li, Mark A. Dayton, Hans J. Berkel
Publikováno v:
International Journal of Cancer. 91:736-739
Insulin-like growth factor-I (IGF-I) has mitogenic and anti-apoptotic effects on breast cancer cells. Epidemiologic studies have shown that high plasma levels of IGF-I and low levels of IGF binding protein (BP)-3 are associated with increased risk of
Publikováno v:
Blood. 92:2118-2122
Chromosomal abnormalities in acute leukemia have led to the discovery of many genes involved in normal hematopoiesis and in malignant transformation. We have identified the fusion partners in an inv(8)(p11q13) from a patient with acute mixed lineage
Publikováno v:
Cytokine. 4:454-460
Interferon gamma (IFN-gamma) production has been attributed exclusively to activated T cells and NK cells. We sought to determine whether human B cells express IFN-gamma. We studied 28 B cell lines including Epstein-Barr virus (EBV)+ normal lymphobla
Publikováno v:
Blood. 80:1289-1298
A recent addition to the lymphokine network is human IL-10 (hIL-10). This novel lymphokine has striking homology to BCRF1 protein, the product of a previously uncharacterized open-reading frame in the Epstein-Barr virus (EBV) genome. To date, IL-10 e
Autor:
William Larry, Gluck, Deborah, Hurst, Alan, Yuen, Alexandra M, Levine, Mark A, Dayton, Jon P, Gockerman, Jennifer, Lucas, Kimberly, Denis-Mize, Barbara, Tong, Dawn, Navis, Anita, Difrancesco, Sandra, Milan, Susan E, Wilson, Maurice, Wolin
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 10(7)
Expansion and activation of natural killer (NK) cells with interleukin-2 (IL-2) may enhance antibody-dependent cellular cytotoxicity (ADCC), an important mechanism of rituximab activity. Two parallel Phase I studies evaluated combination therapy with
Publikováno v:
Cancer immunology, immunotherapy : CII. 48(9)
Mucins have been implicated in tumor-associated immunosuppression. The possibility that colon cancer mucin (CCM) may modulate T-helper 1 (TH1) activity was evaluated by investigating its effect on the production of interleukin-2 (IL-2) by CD4+ cells,
Publikováno v:
Cancer investigation. 14(4)
Twenty-five patients with metastatic malignant melanoma were treated with isotretinoin (13-cis-retinoic acid) orally at 1 mg/kg daily and recombinant interferon alfa-2a (INF-alpha) subcutaneously at 3 million units daily for 16-48 weeks. Therapy was
Publikováno v:
The American journal of medicine. 89(5)
A cute lymphoblastic leukemia (ALL) in adults typically presents fulminantly. However, there are numerous examples in the literature where ALL developed from an antecedent hematologic disorder. These preceding disorders include chronic granulocytic l
Publikováno v:
Analytical Chemistry. 52:2392-2396